Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Daniel Chiu
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Fred Hutchinson Cancer Research Center
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research will include use of SD chip technology and aims to develop novel chip designs. Based on the review of the disclosed financial interests, the design of the proposed research, including Chiu's role as PD/PI for this research, and our ability to manage potential biasing effects arising from those financial interests, as well as taking into account the relative risk and benefits of the research, participation in the research subject is approved with a management plan (found detailed in section 3 of this FCOI report).
Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia
PROJECT NARRATIVE Refining the technical ability to derive accurate data at the bulk and single cell levels, appropriately process and interpret these data, and apply this approach to larger cohorts of cancer patients are crucial next steps for making therapeutically relevant conclusions from single cell and bioinformatic analyses of clonal diversity in cancer. We aim to apply our novel multi-scale approach to understand how tumor cell genetic diversity impacts outcome in acute myeloid leukemia as a demonstration of how this approach might be extended to other cancer types or used in the context of a clinical trial.
Filed on May 03, 2019.
Tell us what you know about Daniel Chiu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Daniel Chiu filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Daniel Chiu | University of Washington | Conflict of Interest | Lamprogen | $60,000 - $79,999 |
| Daniel Chiu | University of Washington | Conflict of Interest | MiCareo | Value cannot be readily determined |
| Daniel Chiu | University of Washington | Conflict of Interest | Lamprogen | Value cannot be readily determined |
| Daniel Chiu | University of Washington | Conflict of Interest | MiCareo | Value cannot be readily determined |
| Daniel Chiu | University of Washington | Conflict of Interest | Lamprogen | Value cannot be readily determined |
| Daniel Chiu | University of Washington | Conflict of Interest | Lamprogen | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.